Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 421-423, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collinson, P. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collinson, P. O.
Related Collections
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1997;43:421-423.)
© 1997 American Association for Clinical Chemistry, Inc.


Editorials

To T or Not to T, That Is the Question

Paul O. Collinson

Consultant Chemical Pathologist, Mayday University Hospital, London Rd., Thornton Heath, Surrey CR7 7YE, UK

The quest for a test that is absolutely disease- and tissue-specific could be considered the Holy Grail of the clinical chemist, dreamt of but seldom achieved. Initial reports on measurement of the cardiac troponins, cardiac troponin T (cTnT) and cardiac troponin I (cTnI), for diagnosis of myocardial infarction suggested that these markers would become the "gold standard," replacing all other existing tests. Questions have been raised as to the specificity of cTnT for cardiac damage in patients with extreme rhabdomyolysis, renal failure, polymyositis, and muscular dystrophy. This problem is addressed by the papers of Bodor et al. (1) and Müller-Bardorff et al. (2) in this issue of Clinical Chemistry. This is therefore a reasonable time to review what we know at the basic science level and how this relates to both papers and current clinical practice.

Cardiac and skeletal muscle cells are closely related but arise from different embryonic lineages and express distinctive gene sets when terminally differentiated. During embryonic development, both muscle types cross-express several genes. There are three troponin T genes, corresponding to slow skeletal, fast skeletal, and cardiac troponin. During early embryonic development, the cTnT gene is activated and transcribed at relatively low levels in both cardiac and skeletal muscles until mid-fetal development, when expression is divergently regulated. In cardiac cells, transcription of the cTnT gene is sharply up-regulated, whereas in the skeletal cells it is repressed (3)(4)(5). Similarly, three isoforms of troponin I exist, also the products of three separate genes: fast skeletal muscle, slow skeletal muscle, and cardiac muscle troponin I. During fetal development, slow skeletal muscle troponin I is the predominant isoform in the heart. After birth, the slow skeletal isoform is lost such that, by 9 months of postnatal development, the cardiac . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
S. Fredericks, J. F. Murray, N. D. Carter, A. M.S. Chesser, S. Papachristou, M. M. Yaqoob, P. O. Collinson, D. Gaze, and D. W. Holt
Cardiac Troponin T and Creatine Kinase MB Content in Skeletal Muscle of the Uremic Rat
Clin. Chem., June 1, 2002; 48(6): 859 - 868.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A C R Rao, N Naeem, C John, P O Collinson, R Canepa-Anson, and S P Joseph
Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation
Heart, September 1, 1998; 80(3): 229 - 230.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
D. S. Ooi and A. A. House
Cardiac troponin T in hemodialyzed patients
Clin. Chem., July 1, 1998; 44(7): 1410 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
O. Hetland and K. Dickstein
Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting
Clin. Chem., July 1, 1998; 44(7): 1430 - 1436.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Fredericks, G. Merton, M.-J. Lerena, D. W. Holt, G. S. Bodor, F. S. Apple, and E. M. Voss
Markers of Myocardial Damage
Clin. Chem., February 1, 1998; 44(2): 362 - 365.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.